PO Box 12153, Chelmsford, Essex CM3 9AZ
01245 327763
5 (Demo)

Accessing Medicines During the Last Year of Life: An Invitation to Participate in a National Survey

Patient access to medicines during the last year of life is critical for control of symptoms.  Yet there is evidence that access is often experienced by patients as difficult, complex and demanding.

As part of a National Institute for Health Research funded study, we are conducting a brief, on-line survey of health care professionals, to capture views on providing patients and carers with access to palliative care medicines, and on what facilitates and prevents good practice.

Your views will contribute to a national picture of current practice which will inform the next phases of our research, and ultimately, help shape national policy and practice enabling patients to have good access to medicines.  Further details about the research can be found on the NIHR website: https://www.journalslibrary.nihr.ac.uk/programmes/hsdr/165223/#/

We are asking registered healthcare professionals within England, who provide palliative and end-of-life care to adults in the community, to complete the on-line survey https://leeds.onlinesurveys.ac.uk/actmed-survey which will take approximately 10-15 minutes.  Please complete it if you are a:

  • Palliative care clinical nurse specialist who is community based
  • Community nurse (RN qualified)
  • Primary care pharmacist employed by GP practice(s)
  • Community pharmacist working in community pharmacy

We look forward to receiving your completed questionnaire by 30th September 2018

For further details about the survey please read the Participant Information Sheet http://medhealth.leeds.ac.uk/downloads/download/1496/actmed_participant_information_sheet

If you have any queries about the research, or would like to be added to the list for dissemination of study results, please contact Dr Natasha Campling via email at actmed@soton.ac.uk

Thank you in advance for your help with this important study.

Professor Sue Latter

Chief Investigator

Leave a comment